Throughout evolution, microbes have developed a variety of means for subverting the host's normal cellular components in order to aid in their colonization of host tissue. Similarly, the host has devised a plethora of responses aimed at preventing colonization or at least ridding itself of the infectious agent once it has gained a foothold. Often times, determining whether a response is more beneficial to the host or to the invading pathogen can be difficult.
The syndecans are a family of four, type-I transmembrane heparan sulfate proteoglycans (HSPGs) that, together with the lipid-linked glypicans, represent the major source of heparan sulfate on the cell surface. The syndecans bind to a wide variety of soluble and insoluble extracellular effector molecules such as extracellular matrix components, growth factors, cytokines, and microbial pathogens. In a study recently published in Glycobiology, we examined the expression of syndecan-4 in gastric epithelial cells and macrophages [1] . In response to infection with the human gastric pathogen Helicobacter pylori, gastric epithelial cells increased the expression of syndecan-4 as measured both by mRNA levels and cell surface staining. Furthermore, we demonstrated that syndecan-4 expression could also be increased by stimulation of the epithelial cells or macrophages with agonists specific for members of the Toll-like receptor (TLR) family that are the principal cell surface receptors responsible for sensing microbial associated products. Like a great many other genes involved in the inflammatory response, enhanced gene expression was shown to be dependent on binding of the NF-κB transcription factor to a specific sequence within the promoter of the human syndecan-4 gene. Our findings thus add to the growing body of evidence that suggests that syndecan-4 may play a significant role in the host response to microbial infection.
Several previous studies have indicated that syndecan-4 expression can be enhanced during an inflammatory response. Two in vitro studies indicated that syndecan-4 expression could be enhanced in endothelial cells or HeLa cells in response to TNF-α, a cytokine commonly induced during inflammation and infection [2, 3] . Furthermore, a 2001 study from Ishiguro and colleagues demonstrated increased syndecan-4 expression in the liver and macrophages in a mouse endotoxemia model [4] . Perhaps more intriguingly, that same study demonstrated increased endotoxin-induced mortality in syndecan-4-deficient mice perhaps as a result of a decreased ability of the macrophages to bind TGF-β, which acts to inhibit inflammatory responses. Syndecan-2 has also been indicated to be expressed inducibly in human monocyte-derived macrophages [5] . Conversely, syndecan-1 expression in two colonic epithelial cell lines is down-regulated by treatment with TNF-α or IL-1β [6] . Thus, ample evidence is now accumulating that shows that levels of syndecan expression can be regulated during an inflammatory response. While this response to injury or infection may be viewed by the host as beneficial during the healing and resolution phase via enhancing responses to cytokines, growth factors, and chemokines (examples of which have been variably shown to bind syndecan family members [7, 8, 9] ), it also appears that pathogens too have evolved the means to use HSPGs to their own benefit.
Many pathogens have been shown to bind specifically to HSPGs expressed on eukaryotic cell surfaces [10] . Furthermore, an increasing number of published studies are demonstrating links between the syndecan family members, in particular syndecans-1 and -4, and bacterial or viral infections. Roles for syndecan-1 and -4 in mediating bacterial/epithelial cell interactions were first demonstrated in a paper by Freissler et al. [11] . When overexpressed in HeLa cells, both syndecan-1 and -4 led to increased Neisseria gonnorrhoeae invasion, which was critically dependent on the presence of the cytoplasmic domains of both syndecans. These results imply that the syndecans are not only serving as receptors for the bacteria, but in fact, play an active role in the invasive process by transmitting a signal to the cytoskeleton. Other human pathogenic bacteria including Orientia tsutsugamushi (the causative agent of scrub typhi) [12] , Listeria monocytogenes, Streptococcus pyogenes, and Staphylococcal sp., among others [13] , have also been demonstrated to utilize syndecans-1 and/or -4 for binding to cell surfaces. Like a number of other cell surface receptors, the syndecan ectodomains are shed from the cell surface both constitutively during the course of heparan sulfate turnover and in a regulated fashion in response to tissue injury, growth factor stimulation, and microbial infection [14, 15] . At least one pathogen, Pseudomonnas aeroginosa, has learned to use shed syndecan-1 for its own benefit [16, 17, 18] . P. aeruginosa, through its virulence factor LasA, induces the in vitro shedding of syndecan-1 from epithelial cells [17] . Surprisingly, syndecan-1-deficient mice are more resistant to P. aeruginosa infection, but become susceptible when given purified syndecan-1 ectodomains, indicating that P. aeruginosa exploits the shedding of syndecan-1 ectodomains as a virulence factor [16] . Syndecan-1 ectodomain shedding has also been observed to be induced by the α and β toxins of Staphyloccous aureus, suggesting that this may be a common virulence mechanism used by a variety of bacterial species.
While we have demonstrated that syndecan-4 expression can be significantly up-regulated in response to H. pylori infection, the implications of this response remain unclear. Like other pathogens discussed above, H. pylori may exploit cell surface HSPGs in order to bind host cells [20, 21, 22] . Ruiz-Bustos and colleagues identified several heparan sulfate binding proteins (HSBPs) from H. pylori that could potentially interact with soluble or cell surface HSPGs [23] . The same group also demonstrated that a 71.5-kDa extracellular HSBP could, in fact, participate in the binding of H. pylori to either HeLa S3 or Kato III cells [24] . Additionally, Utt et al. have provided evidence suggesting that the vaculating toxin of H. pylori, vacA, may utilize heparan sulfate as a cell surface receptor [20] . Thus, there is significant evidence to suggest that HSPGs expressed on the surface of epithelial cells may participate in the host response to H. pylori infection. How the syndecans participate in the host response to H. pylori remains open to speculation. As illustrated in Fig. 1 , one mechanism would suggest that H. pylori utilizes syndecans to bind to the gastric epithelial surface as an aid in colonization. However, a second possible model can be envisioned whereby the shedding of syndecan ectodomains from the cell surface plays a protective role by acting as a soluble "decoy receptor" thereby decreasing H. pylori binding to the cell. These issues are currently being addressed in our laboratory and it is hoped that the results of these studies will open up new avenues for the use of syndecan-based reagents as therapeutics for the treatment of H. pylori and other microbial infections. In one model, the increased expression of syndecan-4 on the surface results in increases in binding of the bacteria, inflammation, and subsequent tissue damage. Alternatively, syndecan-4 shed from the surface of activated epithelial cells acts as a "decoy receptor" for the bacteria resulting in decreases in both colonization and inflammation thereby acting as a protective mechanism.
